Primary experimental recordPositive observation

PMC10043419::ACT000062

MPI-C

Evidence text

Paper-level observation

Tumor growth curves shown in Figure 3C depicted different therapy efficacies of OMVs ... OMV^MPI-SP and OMV^MPI-C treatments resulted in better therapeutic outcomes with statistical significance when compared with the PBS group.

figureConfidence: medium

Assay observation

Activity

Anticancer

Subtype

Cytotoxic

Measure

survival_rate

Comparator

Raw observation

tumor growth restricted

Normalized measurement

Not reported by source

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Mus musculus

Assay method

Not reported by source

Sequence

Not reported by source

Standardization

insufficient information

Source publication

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy

Frontiers in Immunology · 2023

DOI 10.3389/fimmu.2023.1129771 PMC10043419

Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.